September 2, 2014
Fitch Even partner Amanda Lowerre O’Donnell will be a featured presenter at the Practising Law Institute’s Advanced Patent Prosecution Workshop 2014: Claim Drafting & Amendment Writing, taking place on September 11–12, 2014, at the InterContinental Chicago.
The program is designed for private or corporate practitioners with patent experience who wish to improve their general claim drafting and amendment writing skills. Amanda will participate in four separate panel discussions during the workshop: “Advanced Specification Drafting Issues” and “Advanced Claim Drafting Issues” on September 11 and “Advanced Patent Prosecution Issues” and “Advanced Amendment Drafting” on September 12, all as they relate to the electromechanical arts.
Amanda will also be one of three instructors facilitating two interactive workshops: “Advanced Claim Drafting” on September 11 and “Advanced Amendment Drafting” on September 12. During these sessions, attendees will learn to apply substantive patent law to practical patent prosecution problems and will receive individualized feedback on claim drafting and amendment writing exercises.
For more information on the workshop, please visit the PLI website.
Amanda focuses her practice primarily on patent prosecution, patent licensing, commercial clearance assessments, and patent portfolio management. She counsels clients in the U.S. and abroad working in a variety of technical fields and product applications, including electronic components, energy and renewable energy applications, food processing, packaging technology, and medical devices. In addition, Amanda regularly advises clients on business method protections and regarding open-source software issues.
IP Alert | Stock Ownership Leads to Vacatur of $2.75B District Court JudgmentAugust 8, 2022
On June 23, in Centripetal Networks v. Cisco Systems, the Federal Circuit vacated judgment of the district court because stock held by the judge's wife violated the recusal statute and was not harmless error. Read more
IP Alert | Rehearing Reverses Earlier Federal Circuit Decision Finding Silence Supported Negative Claim LimitationJuly 6, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation was not supported by silence in the patent's specification. Read more